Kimberly Dowd

Dr. Kimberly Dowd

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

7 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
KLKate Luisi
Kate Luisi
KMKaitlyn Morabito
Kaitlyn Morabito
KBKatherine E. Burgomaster
Katherine E. Burgomaster
MSMayuri Sharma
Mayuri Sharma
WKWing-Pui Kong
Wing-Pui Kong
DYDong Yu
Dong Yu
A Zika self-amplifying mRNA vaccine delivered by a flexible bedside mixing formulation induces protective immunity in NHPs.

29 September 2018 in Annual Review of Virology
Verified
Journal Article
Closed access
KDKimberly Dowd
Kimberly Dowd
TPTheodore C. Pierson
Theodore C. Pierson
Flaviviruses are arthropod-borne RNA viruses that are a significant threat to global health due to their widespread distribution, ability to cause severe disease in humans, and capacity for explosive spread following introduction into new regions. Members of this genus include dengue, tick-borne encephalitis, yellow fever, and Zika viruses. Vaccination has been a highly successful means to control flaviviruses, and neutralizing antibodies are an important component of a protective immune response. High-resolution structures of flavivirus structural proteins and virions, alone and in complex with antibodies, provide a detailed understanding of viral fusion mechanisms and virus-antibody interactions. However, mounting evidence suggests these structures provide only a snapshot of an otherwise structurally dynamic virus particle. The contribution of the structural ensemble arising from viral breathing to the biology, antigenicity, and immunity of flaviviruses is discussed, including implications for the development and evaluation of flavivirus vaccines.

18 December 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
KRKoen K.A. Van Rompay
Koen K.A. Van Rompay
RKRebekah I. Keesler
Rebekah I. Keesler
Amir ArdeshirAmir Ardeshir
Amir Ardeshir
JWJennifer Watanabe
Jennifer Watanabe
JUJodie Usachenko
Jodie Usachenko
BGBarney S. Graham
Barney S. Graham
A Zika virus vaccine administered to macaques before conception reduces maternal viremia and improves fetal outcomes.

10 June 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SMSonia Maciejewski
Sonia Maciejewski
TRTracy Ruckwardt
Tracy Ruckwardt
KMKaitlyn Morabito
Kaitlyn Morabito
BFBryant M. Foreman
Bryant M. Foreman
KBKatherine E. Burgomaster
Katherine E. Burgomaster
TPTheodore C. Pierson
Theodore C. Pierson
Analysis of antibodies elicited by related Zika virus DNA vaccines revealed protection correlates with a capacity to neutralize mature virions.

3 March 2014 in Viruses
Verified
Journal Article
Open access
PDF file
SAS. Kyle Austin
S. Kyle Austin
KDKimberly Dowd
Kimberly Dowd
West Nile virus (WNV) has become the principal cause of viral encephalitis in North America since its introduction in New York in 1999. This emerging virus is transmitted to humans via the bite of an infected mosquito. While there have been several candidates in clinical trials, there are no approved vaccines or WNV-specific therapies for the treatment of WNV disease in humans. From studies with small animal models and convalescent human patients, a great deal has been learned concerning the immune response to infection with WNV. Here, we provide an overview of a subset of that information regarding the humoral and antibody response generated during WNV infection.